trending Market Intelligence /marketintelligence/en/news-insights/trending/a7O8dIMz8uD-RTfl-o6enA2 content esgSubNav
In This List

Federal court dismisses injunction against Sirtex Medical's A$30M share buyback

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Federal court dismisses injunction against Sirtex Medical's A$30M share buyback

Sirtex Medical Ltd. said the Federal Court of Australia dismissed an injunction application which had delayed the company's A$30 million on-market share buyback.

The company said it plans to proceed with the buyback June 7.

As of May 26, US$1 was equivalent to A$1.34.